MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

07 Nov 2022 Evaluate
The sales for the September 2022 quarter moved up 36.08% to Rs. 476.91 millions as compared to Rs. 350.47 millions during the corresponding quarter last year.The company has announced a 35.59% increase in its profits to Rs . 186.99  millions for the  quarter ended September 2022 compared to Rs. 137.91 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 257.98 millions from 191.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 476.91 350.47 36.08 926.35 674.87 37.26 1148.54 905.63 26.82
Other Income 13.96 7.15 95.24 28.19 18.48 52.54 40.50 32.67 23.97
PBIDT 257.98 191.60 34.65 500.00 370.17 35.07 620.95 435.95 42.44
Interest 0.42 1.26 -66.67 1.04 3.22 -67.70 8.28 9.81 -15.60
PBDT 257.56 190.34 35.32 498.96 366.95 35.97 612.67 426.14 43.77
Depreciation 5.79 5.77 0.35 11.49 11.18 2.77 22.33 17.32 28.93
PBT 251.77 184.57 36.41 487.47 355.77 37.02 590.34 408.82 44.40
TAX 64.78 46.66 38.83 122.77 88.63 38.52 154.10 107.02 43.99
Deferred Tax 2.66 0.18 1377.78 0.74 -0.24 -408.33 0.72 1.26 -42.86
PAT 186.99 137.91 35.59 364.70 267.14 36.52 436.24 301.80 44.55
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 54.09 54.67 -1.05 53.98 54.85 -1.60 54.06 48.14 12.31
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..